IRCT138804132000N2.

Study name	Public title: Neurofeedback in the treatment of attention deficit hyperactivity disorder Scientific title: Effectiveness of neurofeedback versus methylphenidate in the treatment of children with attention deficit hyperactivity disorder
Methods	Parallel RCT Study duration: 3 months
Participants	Sample size (target): 90 Inclusion criteria: Diagnosis of ADHD based on DSM‐IV criteria by child and adolescent psychiatrists Age of 7‐18 years IQ > 85 based on WISC‐III‐R Exclusion criteria: Major learning problems Request of parent to exit from the study Use of antipsychotic drugs in the month before the initiation of the study History of neurofeedback intervention at least for 10 sessions
Interventions	Neurofeedback MPH (starting at 5 mg) MPH plus neurofeedback MPH dose will be adjusted based on optimal dose by a child and adolescent psychiatrist who visits all the participants. They will be assessed 1 week before the start and each month through the study. The last assessment will be on a week after the completion of the research. The rater will be blind to the groups of participants.
Outcomes	ADHD symptoms Conners. Timing of outcome assessment not reported
Starting date	22 December 2014
Contact information	Name: Dr Javad Alaghband Rad, Associate Professor, Child & Adolescent Psychiatrist Affiliation: Tehran University of Medical Sciences, Roozbeh Hospital, South Kargar Street, Tehran Telephone: + 98 21 5541 9151 Email: alaghbandrad@gmail.com
Notes	Sponsor: Behavioral Sciences Research Center, Shahid Beheshti University of Medical Sciences Declaration of interests: not reported